Publications

Publications

Filter Results: (1,253) Arrow Down
Filter Results: (1,253) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 20 of 1,253 Results →
  • Web

Faculty & Advisors - MBA

and served as a Board Observer for Crinetics Pharmaceuticals (NASDAQ: CRNX), among others. Earlier in her career Dr. Chang was a Project Leader at The Boston Consulting and a member of the Healthcare Practice. Dr. Chang trained clinically... View Details
  • January 2023 (Revised August 2023)
  • Case

Veeva Systems and the Transformation to a Public Benefit Corporation

By: Ranjay Gulati and Allison M. Ciechanover
Peter Gassner, the co-founder and CEO of Veeva Systems, steered the company through rapid scaling from its launch in 2007 to 2022. Year after year, the company had exceeded expectations, with its market capitalization reaching $50 billion at its peak. By 2022, the... View Details
Keywords: Transformation; Corporate Governance; Corporate Social Responsibility and Impact; Mission and Purpose; Organizational Culture; Information Technology Industry; Technology Industry; United States; California
Related

    Jay W. Lorsch

    Jay W. Lorsch is the Louis Kirstein Professor of Human Relations at the Harvard Business School. He is editor of View Details

    • August 2011 (Revised October 2011)
    • Case

    PureTech Ventures in 2011

    By: Andrei Hagiu, Cesar Castro and Sarah Murphy
    In early May 2011, Daphne Zohar, founder and managing partner of PureTech Ventures, a life science venture creation company in Boston, MA, was reviewing a term sheet she had just received from a venture capital (VC) firm for one of PureTech's portfolio companies. The... View Details
    Keywords: Business Ventures; Business Startups; Venture Capital; Investment; Innovation and Invention; Negotiation; Partners and Partnerships; Science-Based Business; Opportunities; Boston
    Related
    • September 2007
    • Article

    Investigative Negotiation

    By: Deepak Malhotra and Max H. Bazerman
    This article includes a one-page preview that quickly summarizes the key ideas and provides an overview of how the concepts work in practice along with suggestions for further reading. Negotiators often fail to achieve results because they channel too much effort into... View Details
    Keywords: Knowledge Acquisition; Knowledge Use and Leverage; Negotiation Process; Negotiation Tactics; Motivation and Incentives; Perspective; Pharmaceutical Industry
    Related
    • 02 Feb 2021
    • Blog Post

    Finding My Focus in Health care Amidst a Global Pandemic

    decade, legislators have passed countless health care policies that impact how hospitals, insurance companies and pharmaceutical manufacturers deliver services to patients. Even more, the ongoing SARS-CoV-2 pandemic has uncovered major... View Details
    • January 2001 (Revised July 2003)
    • Case

    Pharmacyclics: Financing Research & Development

    By: Malcolm P. Baker, Richard S. Ruback and Aldo Sesia
    Pharmacyclics (NASDAQ: PCYC), a pharmaceutical company that manufactures products that will improve existing therapeutic treatments for cancer, arteriosclerosis, and retinal disease, was considering a $60 million private placement in February 2000. The company had more... View Details
    Keywords: Valuation; Cash Flow; Financing and Loans; Business Startups; Financial Strategy; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry
    Related

      Francesca Gino

      Francesca Gino is an award-winning researcher who focuses on why people make the decisions they do at work, and how leaders and employees have more productive, creative and fulfilling lives. She is the best-selling author, most recently, of “View Details

      Keywords: pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals; pharmaceuticals
      • March 2011 (Revised February 2012)
      • Case

      Innovation and Growth at Actelion Ltd.

      By: Gary P. Pisano, Daniela Beyersdorfer and Ruth Dittrich
      In late 2010, Jean-Paul Clozel, CEO of the Swiss biotech pharmaceuticals firm Actelion, looks back on a successful decade. The small venture that he had started with a few of his scientist colleagues in the late 1990s to discover novel medicine in a research-driven... View Details
      Keywords: Business Model; Talent and Talent Management; Innovation and Management; Leadership; Growth and Development Strategy; Product Development; Organizational Culture; Research and Development; Pharmaceutical Industry; Pharmaceutical Industry; Switzerland
      Related
      • Web

      MS/MBA Biotechnology: Life Sciences - MBA

      advanced degrees (MD or PhD), will encounter a breadth and depth of science and medicine they have not had in their undergraduate and graduate training. The faculty comprise fundamental scientists and and clinicians, many with experience in founding or running... View Details

        Henry W. McGee

        Henry McGee joined the HBS faculty in 2013 after retiring as President of HBO Home Entertainment, the digital and DVD program distribution division of Home Box Office, the pioneering premium television company. A member of the Entrepreneurial Management Unit,... View Details

        Keywords: television; motion pictures; media; e-commerce industry; entertainment; broadcasting; distribution; health care; journalism; wholesale; arts; nonprofit industry
        • 11 Sep 2007
        • First Look

        First Look: September 11, 2007

        Limited was facing significant pricing pressure in their cash cow business, that primarily consisted of manufacturing Active Pharmaceutical Ingredients (APIs). To combat this commoditization, Biocon's leadership had chosen an... View Details
        Keywords: Martha Lagace
        • January 2014 (Revised December 2014)
        • Case

        GenapSys: Business Models for the Genome

        By: Richard G. Hamermesh, Joseph B. Fuller and Matthew Preble

        GenapSys, a California-based startup, was soon to release a new DNA sequencer that the company's founder, Hesaam Esfandyarpour, believed was truly revolutionary. The sequencer would be substantially less expensive—potentially costing just a few thousand dollars—and... View Details

        Keywords: DNA Sequencing; Life Sciences; Business Model; Innovation ＆ Entrepreneurship; Health Care and Treatment; Genetics; Business Strategy; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States
        Related
        • April 2009
        • Case

        GSK's Acquisition of Sirtris: Independence or Integration?

        By: Toby E. Stuart and James Weber
        An executive from pharmaceutical company GSK must choose how much to integrate a recently acquired biotechnology firm, Sirtris. Moncef Slaoui, GSK's global head of R&D, championed the acquisition of Sirtris to gain access to its potentially revolutionary science.... View Details
        Keywords: Mergers and Acquisitions; Resource Allocation; Organizational Change and Adaptation; Organizational Culture; Organizational Structure; Research and Development; Science-Based Business; Integration
        Related
        • 04 May 2017
        • News

        The Error at the Heart of Corporate Leadership

        • Web

        FAQs - MBA

        biotechnology or pharmaceutical companies, who go deep into the specifics of fundamental papers and clinical trials, and thereby provide students with approaches, background, and tools that they can bring in their subsequent careers in... View Details
        • October 2019
        • Supplement

        Impax Laboratories: Executing Accretive Transactions (A)

        By: Benjamin C. Esty and Daniel Fisher
        Impax Laboratories was a technology-based pharmaceutical company that used a “dual platform” strategy to sell both generic and branded treatments. While Impax had grown organically for most of its history, it was beginning to use major acquisitions for growth. In the... View Details
        Keywords: Financial Reporting; Financial Statements; Mergers and Acquisitions; Capital Structure; Financial Strategy; Competition; Competitive Advantage; Corporate Strategy; Pharmaceutical Industry; United States
        Related
        • October 2019
        • Case

        Impax Laboratories: Executing Accretive Acquisitions (A)

        By: Benjamin C. Esty and Daniel Fisher
        Impax Laboratories was a technology-based pharmaceutical company that used a “dual platform” strategy to sell both generic and branded treatments. While Impax had grown organically for most of its history, it was beginning to use major acquisitions for growth. In the... View Details
        Keywords: Financial Reporting; Financial Statements; Mergers and Acquisitions; Capital Structure; Competition; Competitive Advantage; Corporate Strategy; Pharmaceutical Industry; United States
        Related
        • Web

        Curriculum - MBA

        sciences including pharmaceutical companies, start-up biotechnology and life science companies, consulting with a focus on biotech/life sciences, policy/ government, or investing focused on biotechnology and life sciences. Second Year... View Details
        • 05 Jul 2017
        • News

        Stop the Meeting Madness